2Lee S,Hong J,Choi S Y,et al.(2004).CpG oligodeoxynucleotides induce expression of proinflammatory cytokines and chemokines in astrocytes:the role of c-Jun N-terminal kinase in CpG ODN-mediated NF-kappaB activation.J Neuroimmunol 153(1-2),50-63.
3Klinman,D M,Currie,D,Gursel,I,et al.(2004).Use of CpG oligodeoxynucleotides as immune adjuvants.Immunol Rev 199,201-216.
4Sandler A D,Chihara H,Kobayashi G,et al.(2003).CpG Oligonucleotides Enhance the Tumor Antigen-specific Immune Response of a Granulocyte Macrophage Colony-stimulating Factor-based Vaccine Strategy in Neuroblastoma.Cancer Res 63,394-399.
5Dastan T,Turan K (2004).In vitro characterization and delivery of chitosan-DNA microparticles into mammalian cells.J Pharm Pharm Sci 7(2),205-214.
6Gupta K C,Ravi Kumar M N (2000).Drug release behavior of beads and microgranules of chitosan.Biomaterials 21(11),1115-1119.
7Illum L (1998).Chitosan and its use as a pharmaceutical excipient.Pharm Res 15,1326-1331.
8Janes K A,Calvo P,Alonso M J (2001).Polysaccharide colloidal particles as delivery systems for macromolecules.Adv Drug Delivery Rev 47(1),83-97.
9Bodmeier R,Chen H G,Paeratakul O (1989).A novel approach to the delivery of micro or nanoparticles.Pharm Res 6(5),413-417.
10Battikhi M N (2003).Occurrence of Salmonella typhi and Salmonella paratyphi in Jordan.New Microbiol 26(4),363-373.
